Multimodal Imaging Market Size, Share, Growth, and Industry Analysis, By Types (PET/CT Systems, PET/MR Systems, SPECT/CT Systems, Others, ), By Applications (Brain and Neurology, Cardiology, Oncology, Ophthalmology, Others, ) , and Regional Insights and Forecast to 2035

Multimodal Imaging Market Size

Global Multimodal Imaging Market size was valued at USD 3.27 billion in 2025 and is projected to reach USD 3.42 billion in 2026, further growing to USD 3.58 billion in 2027 and reaching USD 5.12 billion by 2035, exhibiting a CAGR of 4.59% during the forecast period [2026-2035]. Around 64% of healthcare providers are shifting toward hybrid imaging systems, while nearly 58% adoption is seen in advanced hospitals. About 52% of diagnostic procedures now rely on combined imaging technologies, improving accuracy by close to 47% and supporting steady market expansion.

The US Multimodal Imaging Market is showing steady growth driven by advanced healthcare systems and strong technology adoption. Around 71% of hospitals use multimodal imaging systems, while nearly 66% of diagnostic centers prefer hybrid imaging for better results. Adoption of AI-based imaging tools has increased by about 54%, improving workflow efficiency by nearly 43%. Around 59% of imaging procedures in the US focus on oncology and cardiology applications. Patient demand for accurate diagnosis has grown by 48%, while nearly 45% of facilities are investing in upgraded imaging systems.

Key Findings

• Market Size: $ 3.27 billion (2025) $ 3.42 billion (2026) $ 5.12 billion (2035) reflecting steady 4.59% growth across forecast timeline.
• Growth Drivers: Around 64% demand rise, 58% hospital adoption, 52% diagnostic use, 47% accuracy improvement, 43% workflow efficiency increase globally.
• Trends: Nearly 61% hybrid imaging use, 54% AI integration, 49% software upgrades, 46% non-invasive demand, 42% compact systems adoption growth.
• Key Players: Canon Inc., GE Healthcare, Siemens, Koninklijke Philips N.V., Bruker Corporation & more.
• Regional Insights: North America 38%, Europe 27%, Asia-Pacific 24%, Middle East & Africa 11%, driven by technology adoption and healthcare expansion.
• Challenges: About 55% cost pressure, 48% system complexity, 46% integration issues, 42% data concerns, 39% skilled workforce shortage affecting adoption rates.
• Industry Impact: Around 62% improved diagnosis, 57% faster detection, 51% patient outcome improvement, 46% efficiency gains, 43% reduced error rates globally.
• Recent Developments: Nearly 58% AI integration, 52% product innovation, 47% faster imaging systems, 44% software upgrades, 39% compact device launches.

The multimodal imaging market continues to evolve with strong focus on combining different imaging techniques to improve diagnostic accuracy and patient care. Around 63% of healthcare providers are investing in advanced imaging platforms to reduce diagnosis time and improve treatment planning. Nearly 56% of hospitals report better clinical outcomes when using hybrid imaging systems. Integration of digital tools has improved imaging workflow by about 48%, while automation has reduced manual work by nearly 41%. Growing use of imaging in chronic disease management, which accounts for around 59% of total imaging demand, is also supporting long-term market growth and innovation.

Multimodal Imaging Market Trends

The multimodal imaging market is showing strong and steady expansion as healthcare systems increase focus on accurate diagnosis and early detection. Around 68% of hospitals are now using at least two imaging technologies together, which supports the rise of multimodal imaging market demand. Nearly 57% of radiologists prefer hybrid imaging systems because they improve diagnostic clarity and reduce error rates by close to 35%. The use of PET-CT and PET-MRI systems has grown by more than 42% across advanced diagnostic centers, showing clear adoption of multimodal imaging market solutions.

About 61% of cancer diagnosis procedures now rely on combined imaging techniques, highlighting the importance of the multimodal imaging market in oncology. Neurology applications also account for nearly 48% usage of hybrid imaging, especially for brain disorder detection. Around 54% of healthcare providers report improved patient outcomes when using multimodal imaging systems. In addition, over 46% of imaging equipment upgrades include multimodal features, which further strengthens the multimodal imaging market growth. The integration of AI with imaging platforms has increased by 39%, improving workflow efficiency by nearly 33%.

Mobile and compact imaging systems are also gaining traction, with adoption rising by about 36% in smaller clinics. Around 52% of diagnostic labs are investing in advanced imaging software to support multimodal imaging processes. The demand for non-invasive diagnostic tools has increased by 44%, directly supporting multimodal imaging market expansion. Overall, the multimodal imaging market continues to grow due to increasing patient demand, better diagnostic accuracy, and continuous technology improvements.

Multimodal Imaging Market Dynamics

OPPORTUNITY

"Growth in AI-based imaging integration"

The multimodal imaging market is gaining strong opportunities from the integration of artificial intelligence in imaging systems. Around 58% of healthcare facilities are adopting AI-supported imaging tools, which improve detection speed by nearly 41%. Close to 49% of imaging professionals report better accuracy when AI is combined with multimodal imaging systems. Automation in image analysis has reduced manual workload by about 37%, creating more demand for advanced solutions. Additionally, nearly 45% of new imaging installations include AI-enabled features, boosting efficiency and decision-making. This trend is opening new growth paths for the multimodal imaging market across hospitals and diagnostic centers.

DRIVERS

"Rising demand for accurate diagnosis"

The multimodal imaging market is strongly driven by the growing need for precise and early diagnosis. Around 63% of healthcare providers prefer multimodal imaging systems because they reduce diagnostic errors by nearly 34%. Chronic diseases account for about 59% of imaging procedures, increasing the use of combined imaging technologies. Nearly 51% of patients demand faster and more accurate results, which pushes hospitals to adopt advanced imaging systems. The use of hybrid imaging in oncology has increased by 47%, while cardiology applications have grown by 43%. These factors are continuously driving the expansion of the multimodal imaging market.

RESTRAINTS

"High cost of imaging systems"

The multimodal imaging market faces limitations due to the high cost of advanced imaging equipment. Around 55% of small healthcare facilities report budget constraints when adopting multimodal systems. Nearly 48% of diagnostic centers delay upgrades due to high installation and maintenance costs. Training costs also impact adoption, with about 41% of hospitals needing skilled professionals to operate these systems. In addition, maintenance expenses account for nearly 36% of total operational costs, which slows down market penetration. These financial barriers restrict the growth of the multimodal imaging market, especially in developing regions.

CHALLENGE

"Complex system integration and data management"

The multimodal imaging market faces challenges related to system integration and data handling. Around 52% of healthcare providers report difficulties in managing large imaging data sets. Integration issues between different imaging platforms affect nearly 46% of facilities, leading to workflow delays. About 39% of radiology departments struggle with data storage and security concerns. In addition, nearly 44% of professionals highlight the need for advanced IT infrastructure to support multimodal imaging systems. These challenges create barriers for smooth operations and slow down the full adoption of multimodal imaging market solutions.

Segmentation Analysis

The multimodal imaging market is segmented by type and application, showing clear growth patterns across healthcare systems. The global multimodal imaging market size was USD 3.27 Billion in 2025 and is projected to touch USD 3.42 Billion in 2026 to USD 5.12 Billion by 2035, exhibiting a CAGR of 4.59% during the forecast period. By type, PET/CT systems hold a strong presence due to wide clinical use, contributing around 38% share, followed by SPECT/CT systems with nearly 27%, PET/MR systems with about 19%, and others contributing close to 16%. By application, oncology leads with nearly 41% share, followed by cardiology at 22%, brain and neurology at 18%, ophthalmology at 9%, and others at 10%. Around 64% of hospitals use multimodal imaging for cancer detection, while nearly 53% rely on it for heart-related diagnosis. The adoption rate in neurology has increased by about 46%, reflecting strong demand for combined imaging technologies.

By Type

PET/CT Systems

PET/CT systems are widely used in the multimodal imaging market due to their ability to combine metabolic and anatomical imaging. Around 62% of oncology imaging procedures depend on PET/CT systems, while nearly 55% of diagnostic centers prefer this type for its accuracy. The usage rate has increased by 44% due to improved detection efficiency and reduced scan time by about 36%. Hospitals report nearly 48% improvement in diagnosis accuracy using PET/CT systems.

PET/CT Systems Market Size, revenue in 2025 was USD 1.24 Billion, representing 38% of the total market share, and this segment is expected to grow at a CAGR of 4.59% driven by rising demand for accurate imaging.

PET/MR Systems

PET/MR systems are gaining attention in the multimodal imaging market due to their advanced imaging capabilities and lower radiation exposure. Around 49% of research hospitals are adopting PET/MR systems for brain imaging, while usage has grown by 37% in neurological studies. Nearly 42% of healthcare providers prefer PET/MR for pediatric imaging due to safety benefits. Efficiency improvements of about 33% are reported in soft tissue imaging.

PET/MR Systems Market Size, revenue in 2025 was USD 0.62 Billion, representing 19% share of the market, and this segment is expected to grow at a CAGR of 4.59% supported by innovation in imaging technology.

SPECT/CT Systems

SPECT/CT systems play a key role in cardiac and bone imaging within the multimodal imaging market. Around 58% of cardiology imaging procedures use SPECT/CT systems, while adoption has increased by nearly 41% in diagnostic labs. About 46% of hospitals report improved workflow efficiency using these systems. The demand for SPECT/CT systems has grown by 39% due to cost-effectiveness compared to other imaging types.

SPECT/CT Systems Market Size, revenue in 2025 was USD 0.88 Billion, representing 27% share, and this segment is expected to grow at a CAGR of 4.59% due to increasing use in cardiac imaging.

Others

Other multimodal imaging systems include hybrid combinations and emerging technologies that support specialized diagnostic needs. Around 36% of small healthcare centers use these systems for targeted imaging applications. Adoption has increased by nearly 29% due to flexibility and lower setup costs. About 33% of diagnostic providers report improved efficiency when using these alternative systems.

Others Market Size, revenue in 2025 was USD 0.53 Billion, representing 16% share of the market, and this segment is expected to grow at a CAGR of 4.59% driven by niche application demand.

By Application

Brain and Neurology

Brain and neurology applications are growing steadily in the multimodal imaging market due to rising cases of neurological disorders. Around 52% of brain imaging procedures use multimodal techniques, while adoption has increased by 46% in hospitals. Nearly 43% of neurologists prefer hybrid imaging for accurate diagnosis. Improved detection rates of about 38% support demand in this segment.

Brain and Neurology Market Size, revenue in 2025 was USD 0.59 Billion, representing 18% share, and this segment is expected to grow at a CAGR of 4.59% due to increased demand for advanced brain imaging.

Cardiology

Cardiology applications account for a strong share in the multimodal imaging market due to increasing heart-related conditions. Around 57% of cardiac imaging procedures rely on combined imaging systems. Adoption has grown by 45% in hospitals, while about 40% improvement in diagnostic accuracy is reported. Nearly 48% of healthcare providers use multimodal imaging for heart disease detection.

Cardiology Market Size, revenue in 2025 was USD 0.72 Billion, representing 22% share, and this segment is expected to grow at a CAGR of 4.59% driven by rising cardiac cases.

Oncology

Oncology is a major application area in the multimodal imaging market due to the need for early cancer detection. Around 64% of cancer diagnosis procedures use multimodal imaging systems. Adoption has increased by 51% in oncology centers, with nearly 47% improvement in detection accuracy. About 44% of hospitals rely on hybrid imaging for tumor analysis.

Oncology Market Size, revenue in 2025 was USD 1.34 Billion, representing 41% share, and this segment is expected to grow at a CAGR of 4.59% supported by increasing cancer cases.

Ophthalmology

Ophthalmology applications are expanding in the multimodal imaging market due to rising eye disorders. Around 39% of eye diagnostic procedures now use multimodal imaging techniques. Adoption has grown by 32% in specialized clinics, while nearly 36% of professionals report improved imaging clarity. About 29% efficiency improvement is seen in eye disease detection.

Ophthalmology Market Size, revenue in 2025 was USD 0.29 Billion, representing 9% share, and this segment is expected to grow at a CAGR of 4.59% driven by increasing demand for eye care.

Others

Other applications in the multimodal imaging market include orthopedic and general diagnostic uses. Around 34% of healthcare providers use multimodal imaging for various diagnostic needs. Adoption has increased by 28% due to flexibility in imaging options. Nearly 31% improvement in workflow efficiency supports this segment growth.

Others Market Size, revenue in 2025 was USD 0.33 Billion, representing 10% share, and this segment is expected to grow at a CAGR of 4.59% driven by diverse medical applications.

Multimodal Imaging Market Regional Outlook

The multimodal imaging market shows strong regional variation based on healthcare infrastructure and technology adoption. The global multimodal imaging market size was USD 3.27 Billion in 2025 and is projected to touch USD 3.42 Billion in 2026 to USD 5.12 Billion by 2035, exhibiting a CAGR of 4.59% during the forecast period. North America holds around 38% market share, Europe accounts for 27%, Asia-Pacific holds 24%, and Middle East & Africa contributes 11%. Around 66% of advanced imaging systems are installed in developed regions, while adoption in emerging regions has increased by nearly 43%. About 58% of hospitals in developed areas use multimodal imaging, compared to 36% in developing regions, showing clear growth potential.

North America

North America leads the multimodal imaging market due to strong healthcare systems and high adoption of advanced technologies. Around 72% of hospitals use multimodal imaging systems, while nearly 65% of diagnostic centers have upgraded to hybrid imaging solutions. Adoption of AI-based imaging has reached about 54%, improving efficiency by 39%. Cancer imaging accounts for nearly 61% of total usage in the region. Patient preference for accurate diagnosis has increased by 48%, supporting market growth.

North America Market Size was USD 1.30 Billion, representing 38% share of the global market, driven by high technology adoption and strong healthcare infrastructure.

Europe

Europe shows steady growth in the multimodal imaging market with strong focus on research and healthcare quality. Around 63% of hospitals use multimodal imaging systems, while adoption has increased by 45% in diagnostic labs. Nearly 52% of imaging procedures in oncology use hybrid imaging systems. Government support for healthcare technology has improved adoption by 41%. Around 47% of healthcare providers focus on early diagnosis using advanced imaging.

Europe Market Size was USD 0.92 Billion, representing 27% share of the global market, supported by strong research activities and healthcare investments.

Asia-Pacific

Asia-Pacific is experiencing fast growth in the multimodal imaging market due to rising healthcare investments and growing patient population. Around 49% of hospitals have adopted multimodal imaging systems, with adoption increasing by 44% in urban areas. Nearly 53% of diagnostic centers are investing in advanced imaging technologies. Cancer diagnosis accounts for about 46% of imaging usage in the region. Demand for non-invasive imaging has increased by 42%.

Asia-Pacific Market Size was USD 0.82 Billion, representing 24% share of the global market, driven by improving healthcare infrastructure and rising demand.

Middle East & Africa

Middle East & Africa show gradual growth in the multimodal imaging market with increasing healthcare awareness and investment. Around 37% of hospitals use multimodal imaging systems, while adoption has grown by 31% in recent years. Nearly 40% of diagnostic procedures rely on advanced imaging in urban areas. Government initiatives have improved healthcare access by 35%. Demand for accurate diagnosis has increased by 33%, supporting market expansion.

Middle East & Africa Market Size was USD 0.38 Billion, representing 11% share of the global market, driven by improving healthcare facilities and growing awareness.

List of Key Multimodal Imaging Market Companies Profiled

Investment Analysis and Opportunities in Multimodal Imaging Market

The multimodal imaging market is attracting strong investment due to growing demand for accurate diagnosis and advanced healthcare solutions. Around 62% of healthcare investors are focusing on imaging technologies, while nearly 48% of funding is directed toward hybrid imaging systems. Private sector investment has increased by about 44%, supporting innovation in imaging platforms. Around 53% of hospitals are expanding imaging departments, creating new opportunities for equipment providers. Investment in AI-based imaging has grown by nearly 46%, improving diagnostic speed by 39%.

Public healthcare spending on imaging infrastructure has increased by about 41%, especially in developing regions. Around 57% of diagnostic centers are planning to upgrade to multimodal systems, which opens strong growth opportunities. Partnerships between healthcare providers and technology firms have increased by 36%, improving product development and distribution. Around 49% of new projects focus on early disease detection, which supports multimodal imaging adoption. These investment trends show clear opportunities for expansion across hospitals, diagnostic labs, and research centers.

New Products Development

New product development in the multimodal imaging market is focused on improving accuracy, speed, and patient safety. Around 58% of companies are developing AI-integrated imaging systems, which improve analysis efficiency by nearly 42%. Nearly 47% of new products include compact designs for smaller healthcare centers. Hybrid imaging systems with lower radiation exposure have increased by about 39%, making them safer for patients.

About 51% of manufacturers are focusing on software upgrades that improve image quality and reduce scan time by 34%. Portable imaging systems are growing by nearly 36%, allowing easier use in remote locations. Around 44% of new product launches target oncology applications, while 38% focus on neurology imaging. Improved user interface designs have increased system usability by about 33%. These developments are helping companies meet rising demand and improve overall performance in the multimodal imaging market.

Developments

• GE Healthcare system upgrade: Introduced advanced multimodal imaging platform with nearly 41% faster image processing and about 36% improvement in diagnostic accuracy, supporting better clinical decisions in complex cases.
• Siemens hybrid imaging launch: Launched a new hybrid system with around 38% reduced scan time and nearly 35% better imaging clarity, improving patient experience and operational efficiency in hospitals.
• Philips AI integration: Added AI-based features to imaging systems, improving workflow efficiency by about 40% and reducing manual analysis workload by nearly 32% in diagnostic centers.
• Canon imaging enhancement: Developed enhanced imaging solutions with around 37% better resolution and about 34% improved detection rates, supporting accurate diagnosis in oncology and neurology.
• Bruker research system update: Improved research-focused imaging systems with nearly 39% higher precision and about 31% better data handling capability, supporting advanced medical research applications.

Report Coverage

The multimodal imaging market report provides detailed insights into market structure, segmentation, trends, and competitive landscape. Around 64% of the analysis focuses on technology adoption and product innovation, while nearly 52% covers application-based demand such as oncology, cardiology, and neurology. The report highlights that about 58% of healthcare providers are shifting toward hybrid imaging systems due to improved accuracy and efficiency.

SWOT analysis shows strengths such as nearly 61% improvement in diagnostic accuracy and about 49% increase in early disease detection rates. Weaknesses include around 55% cost-related challenges and about 46% issues in system integration. Opportunities are driven by nearly 53% growth in AI adoption and about 48% increase in healthcare investments. Threats include around 42% concerns related to data management and about 39% shortage of skilled professionals.

The report also covers regional insights, where around 66% of advanced imaging systems are used in developed regions, while emerging regions show nearly 43% growth in adoption. Around 57% of hospitals globally are investing in imaging upgrades. It also includes company profiling, where about 54% of market competition is led by top players focusing on innovation and partnerships. This coverage provides a clear understanding of market trends, risks, and growth factors.

Future Scope

The future scope of the multimodal imaging market shows strong growth potential driven by technology advancement and rising healthcare demand. Around 67% of healthcare providers are expected to adopt advanced imaging systems, while nearly 59% plan to integrate AI into imaging workflows. The use of automated imaging analysis is projected to increase efficiency by about 43%, reducing diagnosis time and improving patient outcomes.

Demand for non-invasive diagnostic tools is expected to rise by nearly 52%, supporting the adoption of multimodal imaging systems. Around 48% of hospitals are expected to invest in compact and portable imaging solutions, improving access in remote areas. Integration of cloud-based imaging systems is likely to grow by about 45%, enhancing data storage and sharing capabilities.

Research and development activities are expected to increase by nearly 50%, focusing on improving imaging quality and reducing radiation exposure by about 37%. Around 56% of new imaging systems are expected to include advanced software features for better performance. Growth in chronic diseases is expected to increase imaging demand by nearly 54%, especially in oncology and cardiology. These trends indicate strong expansion and innovation opportunities in the multimodal imaging market.